Neurocrine Biosciences develops and commercializes therapies for neurological, neuroendocrine, and psychiatric disorders, including its lead product Ingrezza for tardive dyskinesia.
Not currently held by tracked 13F filers — this page aggregates activist, insider, politician and research activity.
from2028 — cross-site stock view. Rebuilt at publish time.